Management of primary sclerosing cholangitis

[1] Ahrendt S A, 1999, J Hepatobiliary Pancreat Surg, V6, P366, DOI 10.1007/s005340050132

[2] ROLE OF S-ADENOSYL-L-METHIONINE IN THE TREATMENT OF INTRAHEPATIC CHOLESTASIS [J]. DRUGS, 1990, 40 : 111 - 123

[3] Oral nicotine in treatment of primary sclerosing cholangitis - A pilot study [J]. DIGESTIVE DISEASES AND SCIENCES, 1999, 44 (03) : 602 - 607

[4] EFFECTS OF LONG-TERM RIFAMPICIN ADMINISTRATION IN PRIMARY BILIARY-CIRRHOSIS [J]. GASTROENTEROLOGY, 1992, 102 (06) : 2077 - 2080

[5] EFFECTS OF NALOXONE INFUSIONS IN PATIENTS WITH THE PRURITUS OF CHOLESTASIS - A DOUBLE-BLIND, RANDOMIZED, CONTROLLED TRIAL [J]. ANNALS OF INTERNAL MEDICINE, 1995, 123 (03) : 161 - 167

[6] URSODEOXYCHOLIC ACID FOR TREATMENT OF PRIMARY SCLEROSING CHOLANGITIS - A PLACEBO-CONTROLLED TRIAL [J]. HEPATOLOGY, 1992, 16 (03) : 707 - 714

[7] Bharucha AE, 2000, AM J GASTROENTEROL, V95, P2338

[8] PHENOBARBITAL EFFECTS IN CHOLESTATIC LIVER-DISEASE [J]. ANNALS OF INTERNAL MEDICINE, 1975, 82 (03) : 310 - 317

[9] BORKJE B, 1985, SCAND J GASTROENTERO, V20, P539

[10] Natural history and prognostic factors in 305 Swedish patients with primary sclerosing cholangitis [J]. GUT, 1996, 38 (04) : 610 - 615

[1] Ahrendt S A, 1999, J Hepatobiliary Pancreat Surg, V6, P366, DOI 10.1007/s005340050132

[2] ROLE OF S-ADENOSYL-L-METHIONINE IN THE TREATMENT OF INTRAHEPATIC CHOLESTASIS [J]. DRUGS, 1990, 40 : 111 - 123

[3] Oral nicotine in treatment of primary sclerosing cholangitis - A pilot study [J]. DIGESTIVE DISEASES AND SCIENCES, 1999, 44 (03) : 602 - 607

[4] EFFECTS OF LONG-TERM RIFAMPICIN ADMINISTRATION IN PRIMARY BILIARY-CIRRHOSIS [J]. GASTROENTEROLOGY, 1992, 102 (06) : 2077 - 2080

[5] EFFECTS OF NALOXONE INFUSIONS IN PATIENTS WITH THE PRURITUS OF CHOLESTASIS - A DOUBLE-BLIND, RANDOMIZED, CONTROLLED TRIAL [J]. ANNALS OF INTERNAL MEDICINE, 1995, 123 (03) : 161 - 167

[6] URSODEOXYCHOLIC ACID FOR TREATMENT OF PRIMARY SCLEROSING CHOLANGITIS - A PLACEBO-CONTROLLED TRIAL [J]. HEPATOLOGY, 1992, 16 (03) : 707 - 714

[7] Bharucha AE, 2000, AM J GASTROENTEROL, V95, P2338

[8] PHENOBARBITAL EFFECTS IN CHOLESTATIC LIVER-DISEASE [J]. ANNALS OF INTERNAL MEDICINE, 1975, 82 (03) : 310 - 317

[9] BORKJE B, 1985, SCAND J GASTROENTERO, V20, P539

[10] Natural history and prognostic factors in 305 Swedish patients with primary sclerosing cholangitis [J]. GUT, 1996, 38 (04) : 610 - 615